Mannkind Corp (MNKD)

$5.85 -0.36 (-5.80%)
Market Cap 1.77B
Revenue (ttm) 285.50M
Net Income (ttm) 27.59M
EPS (ttm) N/A
PE Ratio 57.90
Forward PE 65.79
Profit Margin 9.66%
Debt to Equity Ratio -4.79
Volume 2,560,554
Avg Vol 3,606,324
Day's Range N/A - N/A
Shares Out 307.07M
Stochastic %K 98%
Beta 0.81
Analysts Strong Sell
Price Target $9.61

Company Profile

MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of therapeutic products and services for endocrine and orphan lung diseases in the United States. It offers Afrezza Inhalation Powder, an inhaled insulin used to improve glycemic control in adults with diabetes; the V-Go wearable insulin delivery device, which provides continuous subcutaneous infusion of insulin in adults; and Tyvaso DPI for the treatment of pulmonary arterial hypertension and pul...

Industry: Biotechnology
Sector: Healthcare
Phone: 818 661 5000
Address:
1 Casper Street, Danbury, United States
RockyRambo25
RockyRambo25 Feb. 4 at 7:28 PM
$MNKD The ENTIRE market pullback is all Mike’s fault!!! 🤪 I will say it again…2026 will be a FANTASTIC year for Mannkind!!! Tune out the noise… FDA approvals are coming… Afrezza 2.0….will be HUGE! Cheers!🍸
0 · Reply
MrMulally
MrMulally Feb. 4 at 7:00 PM
$MNKD A big thank you to whoever posted a chart yesterday warning us about this dip today !! 🤣Is it still no resistance once we break $100?
0 · Reply
NatesNotes
NatesNotes Feb. 4 at 6:36 PM
$MNKD We're certainly seeing a lot of false narratives and red herrings being tossed into the stream today as part of the usual suspects trying to drum up sympathy for their bassackwards approach to investing, eh? ;-) #intheirownwords #longestrunningpityparty #knowwhatyouown #factsmatter
0 · Reply
JustAnotherJuggler
JustAnotherJuggler Feb. 4 at 6:33 PM
$MNKD Today's sell off is typical of what happens when there is NO Bad News... It's a set up for a RUN UP. Don't be fooled by short interest.
0 · Reply
JustAnotherJuggler
JustAnotherJuggler Feb. 4 at 6:25 PM
$MNKD Why am I obsessed with MNKD? Because I use Afrezza everyday which allows me to live a Better and Much Simpler life without sticking a needle in myself 8 times a day!
0 · Reply
FrostytheHittman
FrostytheHittman Feb. 4 at 5:59 PM
$MNKD Damnit, they got us again…
1 · Reply
stevemano
stevemano Feb. 4 at 5:55 PM
$MNKD The highest price target for MNKD is $15.00, while the lowest price target for MNKD is $7.00. The average price target represents a forecasted upside of 74.09% from the current price of $5.78.
0 · Reply
clan
clan Feb. 4 at 5:54 PM
$MNKD 9X by '29
0 · Reply
stevemano
stevemano Feb. 4 at 5:52 PM
$MNKD thanks mister hedge fund sheister for free shares! We know you are such an honest pos!
0 · Reply
Nakom
Nakom Feb. 4 at 5:48 PM
$MNKD here’s how Mike will start his third quarter conference call. There has never been a better time to be involved in mankind. All the while underneath his breath he’s saying there’s never been a better time to give me more free shares.
1 · Reply
Latest News on MNKD
MannKind Announces FDA Approval of Updated Afrezza® Label Providing Starting Dose Guidance when Switching from Multiple Daily Injections (MDI) or Insulin Pump Mealtime Therapy

Jan 26, 2026, 6:05 AM EST - 9 days ago

MannKind Announces FDA Approval of Updated Afrezza® Label Providing Starting Dose Guidance when Switching from Multiple Daily Injections (MDI) or Insulin Pump Mealtime Therapy

MoneyShow's Best Investment Ideas For 2026: Part 5

Jan 15, 2026, 12:30 PM EST - 20 days ago

MoneyShow's Best Investment Ideas For 2026: Part 5

HRL HUT IDXX IONQ KDK

6 stocks and ETFs that these unsung market heroes see outperforming in 2026

Jan 12, 2026, 3:57 PM EST - 22 days ago

6 stocks and ETFs that these unsung market heroes see outperforming in 2026

AAPL DT GLD ITRN NVDA OMC UTHR

MannKind Provides Business Updates and 2026 Growth Drivers

Jan 8, 2026, 8:05 AM EST - 27 days ago

MannKind Provides Business Updates and 2026 Growth Drivers

MannKind Shares FUROSCIX® Business Updates

Dec 23, 2025, 8:05 AM EST - 6 weeks ago

MannKind Shares FUROSCIX® Business Updates

MannKind's ReadyFlow Autoinjector: A Game Changer For Heart Failure Patients

Dec 3, 2025, 11:46 AM EST - 2 months ago

MannKind's ReadyFlow Autoinjector: A Game Changer For Heart Failure Patients

MannKind Announces U.S. FDA Accepts for Review its Supplemental New Drug Application (sNDA) of FUROSCIX ReadyFlow™ Autoinjector for the Treatment of Edema in Adults with Chronic Heart Failure or Chronic Kidney Disease

Dec 1, 2025, 8:05 AM EST - 2 months ago

MannKind Announces U.S. FDA Accepts for Review its Supplemental New Drug Application (sNDA) of FUROSCIX ReadyFlow™ Autoinjector for the Treatment of Edema in Adults with Chronic Heart Failure or Chronic Kidney Disease

MannKind to Present at the Jefferies Global Healthcare Conference

Nov 11, 2025, 4:05 PM EST - 3 months ago

MannKind to Present at the Jefferies Global Healthcare Conference

MannKind Corporation (MNKD) Discusses Discontinuation of ICoN-1 Phase III Trial for Nebulized Clofazimine in NTM Lung Disease Transcript

Nov 10, 2025, 1:21 PM EST - 3 months ago

MannKind Corporation (MNKD) Discusses Discontinuation of ICoN-1 Phase III Trial for Nebulized Clofazimine in NTM Lung Disease Transcript

MannKind Provides Update on Phase 3 ICoN-1 Trial of Nebulized Clofazimine for NTM Lung Disease

Nov 10, 2025, 8:00 AM EST - 3 months ago

MannKind Provides Update on Phase 3 ICoN-1 Trial of Nebulized Clofazimine for NTM Lung Disease

MannKind Commemorates Alfred E. Mann's 100th Birthday with New Scholarship Program Supporting Young Adults Living with Diabetes

Nov 6, 2025, 9:00 AM EST - 3 months ago

MannKind Commemorates Alfred E. Mann's 100th Birthday with New Scholarship Program Supporting Young Adults Living with Diabetes

MannKind Corporation (MNKD) Q3 2025 Earnings Call Transcript

Nov 5, 2025, 3:51 PM EST - 3 months ago

MannKind Corporation (MNKD) Q3 2025 Earnings Call Transcript

MannKind Corporation Reports Third Quarter 2025 Financial Results and Provides Business Update

Nov 5, 2025, 8:00 AM EST - 3 months ago

MannKind Corporation Reports Third Quarter 2025 Financial Results and Provides Business Update

MannKind Corporation to Hold 2025 Third Quarter Financial Results Conference Call on November 5, 2025

Oct 29, 2025, 4:05 PM EDT - 3 months ago

MannKind Corporation to Hold 2025 Third Quarter Financial Results Conference Call on November 5, 2025

MannKind: Durable Cash Engine, Optional Catalysts Pending

Oct 15, 2025, 12:55 PM EDT - 4 months ago

MannKind: Durable Cash Engine, Optional Catalysts Pending

MannKind Announces U.S. FDA Accepts for Review its Supplemental Biologics License Application (sBLA) for Inhaled Insulin (Afrezza) in Children and Adolescents Aged 4-17 Years Living with Diabetes

Oct 13, 2025, 8:05 AM EDT - 4 months ago

MannKind Announces U.S. FDA Accepts for Review its Supplemental Biologics License Application (sBLA) for Inhaled Insulin (Afrezza) in Children and Adolescents Aged 4-17 Years Living with Diabetes

MannKind Completes Acquisition of scPharmaceuticals, Accelerating Revenue Growth in Cardiometabolic Care

Oct 7, 2025, 9:02 AM EDT - 4 months ago

MannKind Completes Acquisition of scPharmaceuticals, Accelerating Revenue Growth in Cardiometabolic Care

MannKind Appoints Dr. Ajay Ahuja as Executive Vice President and Chief Medical Officer

Sep 29, 2025, 6:05 AM EDT - 4 months ago

MannKind Appoints Dr. Ajay Ahuja as Executive Vice President and Chief Medical Officer

SCPHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of scPharmaceuticals Inc. - SCPH

Sep 16, 2025, 12:17 PM EDT - 5 months ago

SCPHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of scPharmaceuticals Inc. - SCPH

SCPH

MannKind Corporation (MNKD) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Sep 10, 2025, 7:30 PM EDT - 5 months ago

MannKind Corporation (MNKD) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

MannKind Corporation (MNKD) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript

Sep 7, 2025, 9:55 PM EDT - 5 months ago

MannKind Corporation (MNKD) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript

MannKind Corporation (MNKD) Presents At Cantor Global Healthcare Conference 2025 Transcript

Sep 7, 2025, 9:28 PM EDT - 5 months ago

MannKind Corporation (MNKD) Presents At Cantor Global Healthcare Conference 2025 Transcript

MannKind to Present at Upcoming Investor Conferences

Aug 27, 2025, 4:05 PM EDT - 5 months ago

MannKind to Present at Upcoming Investor Conferences

MannKind Announces Expansion of United Therapeutics Collaboration for Second Inhaled Therapy

Aug 27, 2025, 8:05 AM EDT - 5 months ago

MannKind Announces Expansion of United Therapeutics Collaboration for Second Inhaled Therapy

MannKind, Backed By Blackstone, Expands Cardiorenal Focus With $360 Million Deal

Aug 25, 2025, 1:57 PM EDT - 5 months ago

MannKind, Backed By Blackstone, Expands Cardiorenal Focus With $360 Million Deal

BX

MannKind Corporation (MNKD) Mergers and Acquisition Call Transcript

Aug 25, 2025, 1:36 PM EDT - 5 months ago

MannKind Corporation (MNKD) Mergers and Acquisition Call Transcript

MannKind Corporation (MNKD) Q2 2025 Earnings Conference Call Transcript

Aug 6, 2025, 5:20 PM EDT - 6 months ago

MannKind Corporation (MNKD) Q2 2025 Earnings Conference Call Transcript

MannKind Corporation: A Post-Q2 Assessment

Aug 6, 2025, 4:44 PM EDT - 6 months ago

MannKind Corporation: A Post-Q2 Assessment

MannKind and Blackstone Announce up to $500 Million Strategic Financing Agreement

Aug 6, 2025, 7:10 AM EDT - 6 months ago

MannKind and Blackstone Announce up to $500 Million Strategic Financing Agreement

MannKind Corporation Reports Second Quarter 2025 Financial Results And Provides Business Update

Aug 6, 2025, 7:05 AM EDT - 6 months ago

MannKind Corporation Reports Second Quarter 2025 Financial Results And Provides Business Update

MannKind Corporation to Hold 2025 Second Quarter Financial Results Conference Call on August 6, 2025

Jul 30, 2025, 4:05 PM EDT - 6 months ago

MannKind Corporation to Hold 2025 Second Quarter Financial Results Conference Call on August 6, 2025

Top 3 Health Care Stocks That May Rocket Higher This Quarter

Jun 11, 2025, 7:01 AM EDT - 8 months ago

Top 3 Health Care Stocks That May Rocket Higher This Quarter

MannKind to Highlight Data from Recent Pediatric and Adult Studies of Inhaled Insulin (Afrezza®) at American Diabetes Association's 85th Scientific Sessions in Chicago, June 20-23

Jun 9, 2025, 4:05 PM EDT - 8 months ago

MannKind to Highlight Data from Recent Pediatric and Adult Studies of Inhaled Insulin (Afrezza®) at American Diabetes Association's 85th Scientific Sessions in Chicago, June 20-23

INDYCAR Driver Conor Daly To Share His Personal Diabetes Story and Race Go-Karts With Detroit Area Youth On Thursday, May 29

May 27, 2025, 9:15 AM EDT - 9 months ago

INDYCAR Driver Conor Daly To Share His Personal Diabetes Story and Race Go-Karts With Detroit Area Youth On Thursday, May 29

MannKind: Why I'm Still Bullish Despite Tyvaso DPI Competition

May 27, 2025, 12:02 AM EDT - 9 months ago

MannKind: Why I'm Still Bullish Despite Tyvaso DPI Competition

MannKind Corporation (MNKD) Q1 2025 Earnings Call Transcript

May 8, 2025, 11:34 AM EDT - 9 months ago

MannKind Corporation (MNKD) Q1 2025 Earnings Call Transcript

MannKind Corporation Reports First Quarter 2025 Financial Results and Provides Business Update

May 8, 2025, 8:05 AM EDT - 9 months ago

MannKind Corporation Reports First Quarter 2025 Financial Results and Provides Business Update

MannKind Corporation to Hold 2025 First Quarter Financial Results Conference Call on May 8, 2025

May 1, 2025, 4:05 PM EDT - 9 months ago

MannKind Corporation to Hold 2025 First Quarter Financial Results Conference Call on May 8, 2025

MannKind Teams Up with Juncos Hollinger Racing (JHR) Driver Conor Daly to Drive Awareness of Diabetes and Innovative Treatment Options

Apr 7, 2025, 12:30 PM EDT - 10 months ago

MannKind Teams Up with Juncos Hollinger Racing (JHR) Driver Conor Daly to Drive Awareness of Diabetes and Innovative Treatment Options

MannKind Showcases Efficacy, Safety, and Mealtime Control Data from Recent Pediatric and Adult Studies of Afrezza® at the ATTD Conference, March 19-22

Mar 10, 2025, 6:05 AM EDT - 11 months ago

MannKind Showcases Efficacy, Safety, and Mealtime Control Data from Recent Pediatric and Adult Studies of Afrezza® at the ATTD Conference, March 19-22

MannKind Q4 Review: Solid Financials, But Tyvaso DPI's Market Share In Question

Feb 27, 2025, 10:32 AM EST - 1 year ago

MannKind Q4 Review: Solid Financials, But Tyvaso DPI's Market Share In Question

MannKind Corporation (MNKD) Q4 2024 Earnings Call Transcript

Feb 26, 2025, 9:09 PM EST - 1 year ago

MannKind Corporation (MNKD) Q4 2024 Earnings Call Transcript

MannKind Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Feb 26, 2025, 4:05 PM EST - 1 year ago

MannKind Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

MannKind Corporation to Hold 2024 Fourth Quarter and Full Year Financial Results Conference Call on February 26, 2025

Feb 19, 2025, 4:05 PM EST - 1 year ago

MannKind Corporation to Hold 2024 Fourth Quarter and Full Year Financial Results Conference Call on February 26, 2025

MoneyShow's Best Investment Ideas For 2025: Part 8

Feb 3, 2025, 9:20 AM EST - 1 year ago

MoneyShow's Best Investment Ideas For 2025: Part 8

DELL FNV MSTR SKE SKYE AMSC

MannKind Expands Executive Leadership Team

Jan 6, 2025, 4:30 PM EST - 1 year ago

MannKind Expands Executive Leadership Team

MannKind Corporation: A Speculative Buy On IPF And Diabetes Markets

Dec 17, 2024, 7:16 AM EST - 1 year ago

MannKind Corporation: A Speculative Buy On IPF And Diabetes Markets

MannKind Announces Six-Month Results From Phase 3 INHALE-1 Pediatric Diabetes Trial Utilizing Inhaled Insulin (Afrezza®)

Dec 16, 2024, 6:05 AM EST - 1 year ago

MannKind Announces Six-Month Results From Phase 3 INHALE-1 Pediatric Diabetes Trial Utilizing Inhaled Insulin (Afrezza®)

CDSCO Approves Afrezza® (insulin human) Inhalation Powder in India

Dec 11, 2024, 6:00 AM EST - 1 year ago

CDSCO Approves Afrezza® (insulin human) Inhalation Powder in India

MannKind Corporation (MNKD) Q3 2024 Earnings Conference Call Transcript

Nov 7, 2024, 8:30 PM EST - 1 year ago

MannKind Corporation (MNKD) Q3 2024 Earnings Conference Call Transcript

RockyRambo25
RockyRambo25 Feb. 4 at 7:28 PM
$MNKD The ENTIRE market pullback is all Mike’s fault!!! 🤪 I will say it again…2026 will be a FANTASTIC year for Mannkind!!! Tune out the noise… FDA approvals are coming… Afrezza 2.0….will be HUGE! Cheers!🍸
0 · Reply
MrMulally
MrMulally Feb. 4 at 7:00 PM
$MNKD A big thank you to whoever posted a chart yesterday warning us about this dip today !! 🤣Is it still no resistance once we break $100?
0 · Reply
NatesNotes
NatesNotes Feb. 4 at 6:36 PM
$MNKD We're certainly seeing a lot of false narratives and red herrings being tossed into the stream today as part of the usual suspects trying to drum up sympathy for their bassackwards approach to investing, eh? ;-) #intheirownwords #longestrunningpityparty #knowwhatyouown #factsmatter
0 · Reply
JustAnotherJuggler
JustAnotherJuggler Feb. 4 at 6:33 PM
$MNKD Today's sell off is typical of what happens when there is NO Bad News... It's a set up for a RUN UP. Don't be fooled by short interest.
0 · Reply
JustAnotherJuggler
JustAnotherJuggler Feb. 4 at 6:25 PM
$MNKD Why am I obsessed with MNKD? Because I use Afrezza everyday which allows me to live a Better and Much Simpler life without sticking a needle in myself 8 times a day!
0 · Reply
FrostytheHittman
FrostytheHittman Feb. 4 at 5:59 PM
$MNKD Damnit, they got us again…
1 · Reply
stevemano
stevemano Feb. 4 at 5:55 PM
$MNKD The highest price target for MNKD is $15.00, while the lowest price target for MNKD is $7.00. The average price target represents a forecasted upside of 74.09% from the current price of $5.78.
0 · Reply
clan
clan Feb. 4 at 5:54 PM
$MNKD 9X by '29
0 · Reply
stevemano
stevemano Feb. 4 at 5:52 PM
$MNKD thanks mister hedge fund sheister for free shares! We know you are such an honest pos!
0 · Reply
Nakom
Nakom Feb. 4 at 5:48 PM
$MNKD here’s how Mike will start his third quarter conference call. There has never been a better time to be involved in mankind. All the while underneath his breath he’s saying there’s never been a better time to give me more free shares.
1 · Reply
YolitheDolly
YolitheDolly Feb. 4 at 5:46 PM
$MNKD Did the buyout fall through? Lol.
0 · Reply
Big_N_Long
Big_N_Long Feb. 4 at 5:39 PM
$MNKD
0 · Reply
Dogcatfish
Dogcatfish Feb. 4 at 5:38 PM
$MNKD Crap
0 · Reply
kencoop
kencoop Feb. 4 at 5:31 PM
$MNKD What happened never mind I been here before, hahaha
0 · Reply
Pats6X
Pats6X Feb. 4 at 5:31 PM
$MNKD Surge then Purge.....so easy
0 · Reply
yippiecaye
yippiecaye Feb. 4 at 5:20 PM
$MNKD A daycare with Wi-Fi
0 · Reply
Grunkster1
Grunkster1 Feb. 4 at 5:09 PM
$MNKD 11 years later and its still ground hog day
1 · Reply
Playthegame06
Playthegame06 Feb. 4 at 5:01 PM
$MNKD All are down 4-5%. Hoping for a comeback this afternoon
0 · Reply
Playthegame06
Playthegame06 Feb. 4 at 5:00 PM
$MNKD I thought maybe the tanking was a Convertible Debt issue but my other small caps are following the same pattern.
0 · Reply
MayorofMNKD
MayorofMNKD Feb. 4 at 4:45 PM
$MNKD …for the longs who took the approach of dollar cost averaging five years ago until now it’s been dead money so I understand your plight…. In fact, my money has been dead for five years too, even though I’m up. …. I’ve been saying it over and over when the crooks decide to let this run it will run. I’ve been saying it for the last couple years in hopes that this was our year. Now I’m saying this has to be our year! Good luck to the longs who hold or even buy more!
3 · Reply
Dogcatfish
Dogcatfish Feb. 4 at 4:41 PM
$MNKD Atta Boy Luther!
0 · Reply
firefox2778
firefox2778 Feb. 4 at 4:21 PM
$MNKD Nice nice.....My timing was perfect yesterday. Bought some on the drop and started selling some $5P LT expiration for premiums. Cachin
1 · Reply